Calbindin can serve as a biomarker for distal nephron segment injuries (Iida et al., 2014), nephrotoxicity (Hoffmann et al., 2010), acute kidney injury (Togashi et al., 2012) and drug-induced renal injury (Fuchs et al., 2014). Here, CALB1 is linked to acute kidney injury.